Evidence map›Paper›PMID 35027420›Full record

ArticleBMJ open2022

Understanding the cost of care of type 2 diabetes mellitus - a value measurement perspective.

Gerardine Anne Doyle, Shane O'Donnell, Kate Cullen, Etáin Quigley, Sarah Gibney, Diabetes Literacy Consortium

Abstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gerardine Anne DoyleCollege of Business, University College Dublin, National University of Ireland, Dublin, Ireland gerardine.doyle@ucd.ie.ORCID 0000-0001-8516-4431
Shane O'DonnellCollege of Business, University College Dublin, National University of Ireland, Dublin, Ireland.
Kate CullenCollege of Business, University College Dublin, National University of Ireland, Dublin, Ireland.
Etáin QuigleyApplied Research for Connected Health, University College Dublin, National University of Ireland, Dublin, Ireland.
Sarah GibneyGeary Institute for Public Policy, University College Dublin, Dublin, Ireland.
Diabetes Literacy Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe explore the cost of care of type 2 diabetes mellitus (T2DM) using time-driven activity-based costing (TDABC) and connect that cost to resulting patient health outcomes.

designWe construct six care pathways varying from low-risk to high-risk patients over a 12-month cycle of care. We collect time, resource and cost data on activities in each care pathway and compute a time-driven estimate of cost. Use of patient outcome data highlights the health outcomes achieved.

settingPrimary, secondary and tertiary care.

participantsMedical staff involved in the care of patients with T2DM. PRIMARY AND SECONDARY MEASURES: Primary: resources consumed to provide T2DM care. Secondary: health outcomes for representative patient within each patient category.

resultsBy computing cost of T2DM care and associated complications of chronic kidney disease, active foot disease, moderate risk of active foot disease and myocardial infarction, we show that when patients develop acute complications, significant costs are incurred, as compared with the cost of maintaining a patient at low or moderate risk. Variance analysis further informs decision making by showing the need to have the right personnel doing the right tasks at the right time to control costs.

conclusionsA TDABC approach facilitates an understanding of the drivers of cost in chronic illness care. Our paper highlights the stages in the care pathway where different settings, decision making and a more optimal use of resources could assist with achievement of better patient outcomes.

Indexed as

Diabetes Mellitus, Type 2Chronic DiseaseHumansgeneral diabeteshealth economicshealth policyquality in healthcare

Identifiers

PMID35027420
PMCPMC8762124

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.